NEGTEC, an originator of the Sakura Bloom (SKB) cryptocurrency project, has announced a new donation-based crowdfunding ...
Tokyo based Chugai Pharmaceutical and Nippon Shinyaku have launched Gazyva (obinutuzumab), an anti-CD20 monoclonal antib...
Nissui Pharmaceutical Co., Ltd. is carrying out the trial operation to count colonies cultured in the "simple culture me...
Astellas Pharma and Ironwood Pharmaceuticals, recently announced that approval has been obtained in Japan for the guanyl...
Tokyo-headquartered e-commerce group Rakuten Inc’s CEO and chairman of Rakuten Aspyrian Hiroshi Mikitani has led a...
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada...
Asia's largest exhibition and conference dedicated to the Medical Device Design and Manufacturing industry, "Medtec...
Shire plc has announced that its partner in Japan, Shionogi & Co., Ltd has submitted a New Drug Application (NDA) fo...
Singapore – Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development o...
Eisai Inc. and Merck known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administrati...
Dublin-based Medtronic has announced the commercial launch of the IN.PACT Admiral Drug-Coated Balloon (DCB) in Japan. I...
Japan based Kaneka Corporation has installed continuous manufacturing equipment to be applied to pharmaceutical products...
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...
Researchers at Okayama University developed a supporting device for accurately placing hemodialysis catheters on kidney ...
Takeda has entered into a $100 million partnership with newly-launched biotech Ambys Medicines to support its discovery ...
Qiagen N.V. has announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to p...
Eisai Co., Ltd. announced that it has entered into an agreement to grant exclusive development and marketing rights for ...
Eisai Co., Ltd. and Merck & Co., Inc. announced that the U.S. Food and Drug Administration (FDA) granted Break...
